Core Points - The company has released its 2025 semi-annual report, which provides insights into its operational results, financial status, and future development plans [1] - The board of directors and the supervisory board have both approved the semi-annual report, confirming that the content is true, accurate, and complete [12][13] Company Overview - The company is named Haocen Medical Technology Co., Ltd., with the stock code 002622 [1] - The company has not changed its controlling shareholder during the reporting period [5] Financial Information - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [3] - The company has confirmed that there are no preferred shareholders or changes in preferred shareholder holdings during the reporting period [6] Meeting Details - The fifth board of directors' fifteenth meeting was held on August 28, 2025, with all directors present [2][7] - The supervisory board's fifteenth meeting was also held on August 28, 2025, with all supervisors present [12][13] Document Availability - The full content of the 2025 semi-annual report can be accessed on the designated information disclosure website [9][14]
皓宸医疗科技股份有限公司2025年半年度报告摘要